Florida’s dengue outbreak highlights the importance of recognizing symptoms, identifying warning signs, and preventing mosquito bites. Ubong Johnson, MD, explains local transmission, diagnostic testing, treatment, and practical prevention measures.
|Articles|May 4, 2010
Ansell Launches Antimicrobial Surgical Glove
Advertisement
Ansell today announced the launch of its new GAMMEX® Powder-Free glove with AMT Antimicrobial Technology, at the Annual Congress of the Royal Australasian College of Surgeons in Perth, Australia. According to Ansell it is the first surgical glove which incorporates a proprietary antimicrobial coating to provide an additional level of protection to surgical staff against viruses and bacteria, in the event of a breach during surgery.
The last decade has witnessed a rapid expansion of the medical gloves market globally. Major drivers for this growth are improving healthcare systems around the world and the increasing awareness by healthcare workers that gloves offer an effective protective barrier against contamination from bacteria and viruses. Ansell’s new AMT Antimicrobial Technology reduces surgical staff risks of exposure to bloodborne pathogens through a higher level of protection.
Extensive in vitro laboratory testing showed that the antimicrobial coating killed >99 percent of hepatitis C1 and 99 percent of HIV-1 (strain Mn) within 60 seconds of exposure through a simulated glove breach.
GAMMEX® Powder-Free glove with AMT Antimicrobial Technology also kills between 99.7 percent to >99.999 percent of eight common healthcare infectious bacteria, comprising gram-positive, gram-negative, and drug-resistant bacteria (e.g., MRSA, VRE) within 60 seconds from exposure.
“Ansell’s proprietary AMT Antimicrobial surgical glove technology is the result of intensive and collaborative research, and demonstrates the Company’s ability for industry leading innovation and new product development,” says Magnus Nicolin, CEO of Ansell Ltd. “It also underscores Ansell’s commitment to continuously invest in seeking optimal solutions to better protect healthcare professionals in a world with an increasing number of high-risk pathogens.”
GAMMEX® Powder-Free glove with AMT Antimicrobial Technology features a unique and proprietary inner coating, containing skin friendly agents and chlorhexidine gluconate (CHG), an effective antimicrobial agent commonly found in products such as antiseptics and mouthwash.
Ansell’s AMT Antimicrobial Technology is a world first and is now being launched in Australia. It will be progressively rolled out in all Ansell markets
Reference:
1. Tested versus Bovine Viral Diarrhea Virus (BVDV), a common surrogate for hepatitis C.
Advertisement
Related to this article
Understanding current water quality is a starting point for ST108 implementation. John Kimsey, vice president of processing optimization and customer success for STERISS, spoke about his HSPA presentation on assessing readiness, distinguishing system qualification from routine testing, and understanding where water samples should be collected.
An unexplained death at a Russian plague research institute has prompted international scrutiny. The incident raises questions about laboratory safety, transparent reporting, and infection prevention preparedness while the cause remains unconfirmed.
Behind every landmark in infection prevention, from antimicrobial stewardship guidelines to the COVID-19 town halls that reached flight attendants and teachers, is a generation of physician-scientists who led SHEA through crises, organizational change, and scientific breakthroughs. Infection Control Today traces 30 years of SHEA presidents and the lasting mark they left on the field.
Missing instruments and processing delays can strain OR–SPD relationships. At AORN 2026, John Kimsey, vice president of processing optimization and customer success for STERIS, discusses understanding root causes, exploring off-site reprocessing for ambulatory surgical centers, and using hands-on simulation to help surgical teams see sterile processing from a different perspective.
This week's coverage in Infection Control Today centered on a common thread: the systems, partnerships, and data that let infection prevention teams catch problems before patients are harmed.
UPMC’s genomic surveillance initiative earned national recognition for patient safety. Alexander Sundermann, DrPH, CIC, FAPIC, AL-CIP, explains how the award could help infection preventionists secure leadership support and sustainable funding for earlier outbreak detection.
Knowing the protocol is only the beginning. In The Clean Bite, Sherrie Busby explores how explaining the why, addressing staff concerns, and creating clear procedures can help dental teams make infection control part of everyday practice.
Advertisement
Advertisement